D. Scott Coward - 19 Feb 2025 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
Director
Signature
/s/ D. Scott Coward by Mark Busch, attorney-in- fact
Issuer symbol
EXAS
Transactions as of
19 Feb 2025
Net transactions value
-$33,103
Form type
4
Filing time
21 Feb 2025, 16:30:19 UTC
Previous filing
20 Dec 2024
Next filing
16 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Options Exercise $0 +2,248 +4.4% $0.000000 52,831 19 Feb 2025 Direct F1
transaction EXAS Common Stock Tax liability $33,103 -667 -1.3% $49.63 52,164 19 Feb 2025 Direct F2
holding EXAS Common Stock 4,693 19 Feb 2025 by IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EXAS Restricted Stock Units Options Exercise $0 -2,248 -100% $0.000000 0 19 Feb 2025 Common Stock 2,248 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of common stock received upon vesting of a restricted stock unit award.
F2 Represents shares of Common Stock retained by Exact Sciences Corporation for tax withholding purposes in connection with the net-settlement on the issuance of shares of Common Stock in respect to the vesting of certain restricted stock units.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.
F4 Represents a restricted stock unit award granted on February 19, 2021 that vests in four equal annual installments from the grant date.